
Sign up to save your podcasts
Or


We caught up with Amit Shah and he discussed Virta's mission to reverse Type 2 diabetes and obesity through personalized nutrition and continuous remote monitoring. He also discusses he challenges of scaling Virta's pioneering clinical, technology, and business model - including evolving massive workflows and systems amid rapid growth and how recent GLP-1 obesity drug approvals are tailwinds driving adoption of Virta’s more sustainable, cost-effective solution.
Amit Shah: https://www.linkedin.com/in/amitrshah1/
Chris Hoyd: https://www.linkedin.com/in/chrishoyd/
For the full YouTube video: https://youtu.be/Fl-_SsHEz0Y
Virta Health Website: https://www.virtahealth.com/
Virta Health YouTube: https://www.youtube.com/virtahealth
Product in Healthtech is community for healthtech product leaders, by product leaders. For more information, and to sign up for our free webinars, visit www.productinhealthtech.com.
By Chris Hoyd, Vynyl5
44 ratings
We caught up with Amit Shah and he discussed Virta's mission to reverse Type 2 diabetes and obesity through personalized nutrition and continuous remote monitoring. He also discusses he challenges of scaling Virta's pioneering clinical, technology, and business model - including evolving massive workflows and systems amid rapid growth and how recent GLP-1 obesity drug approvals are tailwinds driving adoption of Virta’s more sustainable, cost-effective solution.
Amit Shah: https://www.linkedin.com/in/amitrshah1/
Chris Hoyd: https://www.linkedin.com/in/chrishoyd/
For the full YouTube video: https://youtu.be/Fl-_SsHEz0Y
Virta Health Website: https://www.virtahealth.com/
Virta Health YouTube: https://www.youtube.com/virtahealth
Product in Healthtech is community for healthtech product leaders, by product leaders. For more information, and to sign up for our free webinars, visit www.productinhealthtech.com.